Skip to main content

Multiple Organ Failure

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Shield Therapeutics
Shield TherapeuticsMA - Wellesley
1 program
Early order of palliative care consultationN/A1 trial
Active Trials
NCT02858778Unknown120
Biocorp
BiocorpFrance - Issoire
1 program
MicroKine Dx systemN/A1 trial
Active Trials
NCT04295278Unknown25Est. Dec 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BiocorpMicroKine Dx system
Shield TherapeuticsEarly order of palliative care consultation

Clinical Trials (2)

Total enrollment: 145 patients across 2 trials

NCT04295278BiocorpMicroKine Dx system

Feasibility Study of MicroKine Dx System in Critically-ill Pediatric Patients.

Start: Jan 2021Est. completion: Dec 202225 patients
N/AUnknown
NCT02858778Shield TherapeuticsEarly order of palliative care consultation

Timing of Acute Palliative Care Consultation in Critically Ill Patients

Start: Jun 2016120 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.